BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment

  September 19, 2025

   · 

  8 min read
• Press Releases

  Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

  September 19, 2025

   · 

  5 min read
• Press Releases

  Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

  September 19, 2025

   · 

  4 min read
• Press Releases

  AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic Hepatitis B

  September 19, 2025

   · 

  3 min read
• Press Releases

  Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

  September 19, 2025

   · 

  5 min read
• Press Releases

  Faron Pharmaceuticals Ltd: Exercise of Options, Director Dealing and Issue of Equity

  September 19, 2025

   · 

  4 min read
• Press Releases

  Genflow Strengthens IP Portfolio

  September 19, 2025

   · 

  5 min read
• Press Releases

  Innovent Announces Mazdutide Received Approval from China’s NMPA for Glycemic Control in Adults with Type 2 Diabetes

  September 19, 2025

   · 

  14 min read
• Press Releases

  DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting

  September 19, 2025

   · 

  3 min read
• Press Releases

  European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

  September 19, 2025

   · 

  9 min read